We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » N.E. AND OTHER MEDTECH REGIONS WOULD BE HIT HARD BY PROPOSED NIH CUTS, BUSINESS LEADER SAYS

N.E. AND OTHER MEDTECH REGIONS WOULD BE HIT HARD BY PROPOSED NIH CUTS, BUSINESS LEADER SAYS

July 7, 2006

A bill recently approved by a House panel has raised concerns in the medical technology industry that research programs sponsored by the National Institutes of Health (NIH) will suffer funding cuts.

The House Appropriations Labor-HHS-Education Subcommittee voted 9-7 along party lines June 7 to approve a draft bill that includes nearly across-the-board cuts in NIH programs. Rep. David Obey (D-Wis.) expressed outrage over the cuts.

Reports have cited concern among researchers, the next generation of potential innovators and industry about the impact of the cuts on medical technology development.

The proposed cuts not only threaten "the development of lifesaving scientific breakthroughs" but also have "a detrimental impact on regional economies that are dependent on innovation -- and New England is at the forefront," said James Brett, president and CEO of the New England Council, in a recent editorial in The Boston Globe. He wants Congress to support a 5 percent increase in NIH funding.

To view the editorial, go to www.boston.com/news/globe/editorial_opinion/oped/articles/2006/07/05/setbacks_for_medical_research/ (http://www.boston.com/news/globe/editorial_opinion/oped/articles/2006/07/05/setbacks_for_medical_research/).

KEYWORDS FDAnews Device Daily Bulletin

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 13Jul

    FDA Ad and Promo Enforcement Trends: Past, Present and Future

  • 28Jul

    EU-MDR’s Growing Pains: Are You Current with the Latest Developments?

  • 28Jul

    Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does

  • 02Aug

    Medical Device Cybersecurity: Understand the Latest Developments

  • 03Aug

    Pharmaceutical Process Validation: Best Practices for Success

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Okami Medical’s LOBO-7 and LOBO-9 Vascular Occluders Cleared

  • FDA Puts Clinical Hold on Astellas Late-Onset Pompe Disease Clinical Trial

  • FDA Provides Update on GE Healthcare’s Recall of Its Carescape R860 Ventilators

  • Gilead Resubmits NDA for Lenacapavir Following Complete Response Letter

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing